 |
|
|
| |
High risk on drug-drug interactions during hepatitis C treatment: a nationwide cohort
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, 2016, Washington, DC, USA
E.J. Smolders1, F.A.C. Berden2, C.T.M.M. de Kanter3, W. Huizinga1, W. Kievit4, J.P.H. Drenth2, D.M. Burger1
1Radboud university medical center, Pharmacy, Nijmegen, The Netherlands; 2Radboud university medical center, Gastroenterology and Hepatology, Nijmegen, The Netherlands; 3University Medical Center Utrecht, Pharmacy, Utrecht, The Netherlands; 4Radboud university medical center, Health Evidence, Nijmegen, The Netherlands
|
| |
|
|
|
|
|
